Test can personalize use of immunotherapy and chemotherapy for head and neck cancer
Test can personalize use of immunotherapy and chemotherapy for head and neck cancer,KN- 048 Mono OS - MConnect GCC,The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK - Vasiliadou - 2024 - International Journal of Cancer - Wiley Online Library,Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC - JTO Clinical and Research Reports,VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer | 2 Minute Medicine